SCHEMBL3358320

SCHEMBL3358320

CN1CC[C@H]1COc1cncc(N2CCC(CCOCc3ccccc3)CC2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 14/20 0.60
CHRNA4 P43681 6/20 0.60
CHRNB4 P30926 10/20 0.52
CHRNA3 P32297 10/20 0.52
CHRNB1 P11230 9/20 0.52
CHRNB3 Q05901 9/20 0.52
JAK2 O60674 1/20 0.52
DAPK3 O43293 1/20 0.49
ROCK2 O75116 1/20 0.49
PRKCG P05129 1/20 0.49
PIM1 P11309 1/20 0.49
RPS6KB1 P23443 1/20 0.49
AKT1 P31749 1/20 0.49
LIMK1 P53667 1/20 0.49
CDK5 Q00535 1/20 0.49
PRKCD Q05655 1/20 0.49
PAK1 Q13153 1/20 0.49
STK3 Q13188 1/20 0.49
ROCK1 Q13464 1/20 0.49
DYRK1A Q13627 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3361626 0.94 CHRNB2 (0.63) CHRNB2CHRNA4CHRNB4CHRNA3CHRNB1
SCHEMBL3358773 0.94 CHRNB2 (0.63) CHRNB2CHRNA4CHRNB4CHRNA3CHRNB1
Hydrochloric Acid SCHEMBL3356701 0.94 CHRNB2 (0.64) CHRNB2CHRNA4CHRNB4CHRNA3CHRNB1
Hydrochloric Acid SCHEMBL3356927 0.94 CHRNB2 (0.64) CHRNB2CHRNA4CHRNB4CHRNA3CHRNB1
SCHEMBL13335336 0.85 CHRNB2 (0.64) CHRNB2CHRNA4CHRNB4CHRNA3CHRNB1
SCHEMBL13335381 0.85 CHRNB2 (0.64) CHRNB2CHRNA4CHRNB4CHRNA3CHRNB1
SCHEMBL13307407 0.84 CHRNB2 (0.61) CHRNB2CHRNA4
SCHEMBL3356498 0.84 CHRNB2 (0.61) CHRNB2CHRNA4
SCHEMBL3356215 0.84 CHRNB2 (0.61) CHRNB2CHRNA4
SCHEMBL3356276 0.84 CHRNB2 (0.42) CHRNB2CHRNA4CHRNB4CHRNA3CHRNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130184313-A1 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AND THE USES THEREOF THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2013-07-18 US disclosed
US-20130184313-A1 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AND THE USES THEREOF THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2013-07-18 US disclosed
US-8445684-B2 Nicotinic acetylcholine receptor ligands and the uses thereof PsycoGenics Inc. (US) 2013-05-21 US disclosed
US-8445684-B2 Nicotinic acetylcholine receptor ligands and the uses thereof PsycoGenics Inc. (US) 2013-05-21 US disclosed
US-20100152450-A1 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AND THE USES THEREOF PSYCHOGENICS, INC. (US) 2010-06-17 US disclosed
US-20100152450-A1 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AND THE USES THEREOF PSYCHOGENICS, INC. (US) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152450-A1 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AND THE USES THEREOF CHRNG, CHRNA5, CHRNA2 CHRNB2 12/4885CHRNA4 5/4885CHRNB4 15/4885
US-20130184313-A1 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AND THE USES THEREOF CHRNG, CHRNA5, CHRNA2 CHRNB2 12/4885CHRNA4 5/4885CHRNB4 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.